skip to main content

Lamotrigine rash — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardCNS TherapeuticsLamotrigine rashGPhC CRA

A 31-year-old woman taking lamotrigine for epilepsy presents with a new widespread rash, fever, and mouth soreness after a recent dose increase. She asks whether to continue until her neurology appointment next month. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DAdvise urgent medical assessment because severe cutaneous reaction is possible

Rash with systemic symptoms and mucosal involvement after lamotrigine initiation or dose escalation may indicate a serious cutaneous adverse reaction. This requires urgent assessment and specialist advice about stopping treatment and future antiepileptic therapy. Symptomatic treatment alone is unsafe.

Reference: BNF; NICE CKS